Survodutide
Survodutide is a novel investigational drug developed as a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucagon receptors, targeting comprehensive management of obesity and related metabolic disorders.
Survodutide
Survodutide is a novel investigational drug developed as a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucagon receptors, targeting comprehensive management of obesity and related metabolic disorders.
| Dosage | 2mg, 5mg, 10mg |
|---|
Reviews
There are no reviews yet.